CD4 and melanoma: This result was similar to that of previous studies that also reported a decrease in infiltrating of CD8+ T cells, Mast cells, and CD4+ T cells in melanoma patients at high risk.27, 28, 29 Patients in the high‐risk group had a decrease in the infiltration of these immune cells which lead to a poor prognosis.